Subspecialties

In an animal model of ischemic retinal disease, a single Ang1 injection suppresses vascular leakage and stimulates blood vessel formation

Interventions by ophthalmologists have an incredible power to improve – and extend – lives. As superpowers go, it’s not quite laser vision, but it’s close enough!

During the DOC 2013 in Nürnberg/Germany the new Geuder MACH2 Double-Blade Vitreous Cutter was introduced. For the first time, the technology of two active blades has been realized in a sterile product.

Dry Eye Disease (DED) is one of the most common problems that we deal with in our clinics. We have seen our dry eye clinic grow exponentially as the baby boomers become older. We completed a 3 year retrospective study showing that over 75%

In Australia, the highly successful collaborative care approach for glaucoma patients has been ripped apart by the optometrists’ regulatory body. Can it be repaired? Ophthalmologists are making a determined effort.

It’s a rare discovery that necessitates changes to anatomy textbooks. Here, Harminder Dua describes how he discovered the eponymous new layer of the cornea, and discusses its significance.

Management approaches for best outcome vary by location. Glaucoma is exceeded only by cataracts as a cause of blindness. In 2002, the World Health Organization estimated that 12.3 million people worldwide had been blinded by glaucoma.

Corneal cross-linking (CXL) is having a transformative impact on the treatment of keratoconus and post-laser ectasia.

The level of hypertensive retinopathy is an independent long-term risk factor. A recent study has demonstrated that retinal photographs can reveal the future stroke risk of hypertensive patients –

Is the future of eyedrops preservative-free? Itching. Irritation. Dry eye. In extreme cases, keratosis and scarring. Adverse events occur in one in 10 patients who are on long-term therapy with eyedrops for conditions like glaucoma or uveitis. For many, these side-effects are caused by preservatives.